RADX (Radiopharm Theranostics) Pangali Forward P/E
The forward P/E of Radiopharm Theranostics (RADX) exhibits volatility driven by the company's reliance on international cooperation and sanction risks associated with component supplies. The value of 0.00 determines this parameter level. The company's efficiency is bolstered by its own express delivery network for short-lived isotopes. Meanwhile, ownership of unique patents in nuclear medicine creates a powerful barrier to entry for new players.
Ringkesan rincian data analitis Radiopharm Theranostics Ltd (RADX)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Radiopharm Theranostics|RADX - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Radiopharm Theranostics Limited|RADX - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Radiopharm Theranostics|RADX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Radiopharm Theranostics|Rasio cepet radiopharmtheranostics.com
- rincian asil keuangan lan kelipatan valuasi:
RADX - Asil keuangan resik|Bathi sing dikarepake Radiopharm Theranostics|RADX - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Radiopharm Theranostics Limited|RADX - Rasio kapitalisasi marang bathi lan wutah|Pangali EV/EBITDA Radiopharm Theranostics|RADX - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Radiopharm Theranostics|RADX - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan radiopharmtheranostics.com|RADX - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Radiopharm Theranostics
- indikator volume dodolan lan pendapatan:
Pambiji fundamental:radiopharmtheranostics.com
The effectiveness of targeted therapy and the stability of isotope supplies determine the future cash flows of Radiopharm Theranostics (RADX), directly impacting expected earnings. By analyzing the company's forward P/E ratio, an investor compares the current share price with projected annual income, which helps identify unjustified market overheating and assess the fairness of the asset's valuation relative to its fundamental prospects.
Analisis perusahaan pesaing
Pangali Forward P/E ONC|HALO (Halozyme Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (revmed.com)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Bio (BCAX) - Rega marang bathi mangsa ngarep|Personalis Corp - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Systems, Inc. DCTH|Prakiraan rega marang bathi YMAB (Y-mAbs Corp)|Pangali Forward P/E Aura Bio (AURA)|Pangali Forward P/E CADL (Candel Therapeutics Inc.)|ARAY - Prakiraan rega marang bathi|SLS - Rega marang bathi mangsa ngarep|Actuate Therapeutics - Rasio kapitalisasi marang bathi mangsa ngarep|CTOR: Pangali Forward P/E|TuHURA (HURA) - Pangali Forward P/E|TARA (Protara Therapeutics Inc) - Pangali Forward P/E|FATE: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E WHWK|TCRX (TScan) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Champions Oncology, Inc. CSBR|XBIT - Prakiraan rega marang bathi|CEL-SCI - Pangali Forward P/E|OSTX - Pangali Forward P/E|ARTV: Pangali Forward P/E|ANL: Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi VERU|TPST: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep xiliotx.com (XLO)|Renovaro - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Mural Oncology MURA|KAPA - Prakiraan rega marang bathi|OKUR - Rega marang bathi mangsa ngarep|GDTC - Pangali Forward P/E|Curis, Inc. (CRIS) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Apollomics, Inc.|Prakiraan rega marang bathi THAR|Rasio rega marang bathi mangsa ngarep ADVB (Advanced Biomed)|Prakiraan rega marang bathi GNPX (Genprex, Inc)|CLDI: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep sunshinebiopharma.com SBFM|XBIO - Prakiraan rega marang bathi|SLRX: Prakiraan rega marang bathi|Purple Biotech - Rasio kapitalisasi marang bathi mangsa ngarep|American Oncology Network (AONC) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep BGNE|Prakiraan rega marang bathi CKPT|Rega marang bathi mangsa ngarep ELEV|Pangali Forward P/E ICAD|Pangali Forward P/E Ikena Oncology Inc. (IKNA)|Pangali Forward P/E NTBL (Notable Labs Ltd)|Kapitalisasi marang proyeksi bathi Viracta Therapeutics (VIRX)|MOR: Prakiraan rega marang bathi|NAYA (NAYA Bio) - Rasio rega marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E
